| Pharmaceutical active ingredients: |
| Naproxen Aminobutanol |
| Available forms, composition and doses of Synalgo: |
| N / A |
| Synalgo medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G02CC02 - NaproxenM01AE02 - NaproxenM02AA12 - Naproxen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Geymonat |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Synalar-HP | Fluocinolone Acetonide | Medicis Pharmaceutical Corporation |
| Synaleve Capsules | Acetaminophen; Codeine Phosphate; Meprobamate | Adcock Ingram |
| Synaleve Syrup | Acetaminophen; Codeine Phosphate; Promethazine Hydrochloride | Adcock Ingram |
| Synaleve Tablets | Acetaminophen; Caffeine; Codeine Phosphate; Meprobamate | Adcock Ingram |
| Synalgesic | Acetaminophen; Dicyclomine Hydrochloride | Wyeth |
| Synalgos | Promethazine | Leitner Pharmaceuticals |
| Synalgos-DC | Aspirin; Caffeine; Dihydrocodeine Bitartrate | Leitner Pharmaceuticals |
| Synalgos-DC-A | Acetaminophen; Caffeine; Dihydrocodeine Bitartrate | Leitner Pharmaceuticals |
| Synalogos | Phenacetin | Unidentified Pharmaceutical Company |
| Synalotic | Ciprofloxacin Hydrochloride; Fluocinolone Acetonide | Yamanouchi; Astellas Pharma |